Novel Therapeutic Devices in Heart Failure

Area of Science:

• Cardiology
• Biomedical Engineering
• Medical Devices

Background:

• Heart failure (HF) presents a major clinical challenge with substantial healthcare costs.
• Improving clinical outcomes in HF necessitates exploring novel therapeutic strategies.
• Device interventions are increasingly investigated for their potential in HF management.

Purpose of the Study:

• To review and present notable device interventions currently under investigation for HF.
• To analyze devices targeting key pathophysiological processes in heart failure.
• To evaluate the evidence, potential targets, and limitations of novel HF devices.

Main Methods:

• A comprehensive review of current literature on investigational devices for HF.
• Categorization of devices based on targeted pathophysiological mechanisms (autonomic imbalance, respiratory disturbances, decongestion).
• Analysis of each device segment including its target, existing evidence, and identified weaknesses.

Main Results:

• Devices targeting autonomic nervous system imbalance include baroreflex activation therapy and nerve modulation techniques.
• Interventions for respiratory disturbances involve phrenic nerve stimulation and synchronized diaphragmatic therapy.
• Several novel systems are presented for decongestion management, such as the Reprieve system and transcatheter renal venous decongestion systems.

Conclusions:

• Novel therapeutic devices offer significant potential for advancing heart failure management.
• Current evidence suggests promise, but further rigorous investigation is required.
• The clinical utility and long-term efficacy of these devices need to be fully evaluated.